Next month is the 5 year anniversary of Science-Based Medicine. We have published 1575 articles so far, with 72,400 comments. We are getting about 475,000 views per month, and SBM has attracted the attention of the mainstream media, government agencies, peer-reviewed journals, and even television and movie producers. Over the last five years we have endeavored to be a valuable resource for anyone interested in the science of medicine, targeting our articles at both a professional and general audience simultaneously.
We are trying to engage with future and current health care professionals with articles about how to evaluate the medical literature, the pros and cons of various approaches to data, and the pitfalls of clinical decision making. We have also tried to serve a consumer protection function by targeting many false and misleading claims for health products. Further we have advocated strongly for effective regulation of health care products and practices to maintain a single, fair, and effective science-based standard of care across all health care.
It seems that we have met our initial goal of creating a successful blog promoting science-based medicine. But there is so much more to do. And we need your support.
I have the pleasure of announcing that this is the 1000th post of Science-Based Medicine. The first post introducing the blog was on January 1st 2008 – almost three years ago. We have published steadily since then, and this post marks number 1000.
I would like to take this time to thank the many regular contributors and editors who have added to the success of SBM, as well as the regular readers and commenters. I would especially like to thank David Gorski, the managing editor, who has done much of the day-to-day management of SBM and is largely responsible for its growth.
We have plans to continue to build SBM into a better and better resource for science in medicine. We are just getting started, so stay tuned.
The editors and crew at SBM have an announcement that needs to be made. This morning, Dr. Amy Tuteur tendered her resignation and will therefore no longer be a blogger at SBM. Some of you might already be aware of this development because Dr. Tuteur has already announced her decision on her own blog. That is why we considered it important to post an announcement here on SBM as soon as possible.
While we are sorry to see Dr. Tuteur go and wish her well in whatever future endeavors she decides to pursue, over the last several weeks it had become clear to both the editors of SBM and Dr. Tuteur herself that, although Dr. Tuteur had routinely been able to stimulate an unprecedented level of discussion regarding the issues we at SBM consider important, SBM has not been a good fit for her and she has not been a good fit for SBM. Over the last few days mutual efforts between the editors and Dr. Tuteur to resolve our differences came to an impasse. Unfortunately for all parties, that impasse appeared to be unresolvable and resulted in Dr. Tuteur’s decision to leave SBM.
As a result of Dr. Tuteur’s departure, we will be adjusting the posting schedule in order to cover her normal Thursday slot. Final decisions have not been made yet, but we expect that every weekday will continue to be covered, with at least one post per weekday.
My inaugural post was about vaccines, and I promised that I wouldn’t write exclusively on this topic. But something rotten is brewing in the state of Georgia and this story is just too important to ignore.
The first successful challenge to the National Childhood Vaccine Injury Compensation Act (NCVICA) has taken place in Georgia, and we all should be just a little bit worried. In Ferrari v. American Home Products Corp., the plaintiffs, Marcello and Carolyn Ferrari of Atlanta, have sued American Home Products Corp. (otherwise known as Wyeth) and the co-defendant GlaxoSmithKline, claiming that the vaccine preservative thimerosal led to their son’s autism. The consequences of this ruling could effect the health of the entire nation. To understand why, we need to delve a bit into what the NCVICA is exactly, and why it was created in the first place.